Cancer Drug News Do certain diabetes drugs increase the risk of acute kidney injury in patients taking anti-cancer therapies?
Protected: Tecartus® (Brexucabtagene Autoleucel) CAR T-cell therapy now funded in Australia for adult relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (r/r ALL)
Cancer Drug News Researchers discover drug resistance mechanism in leukemia, ID treatment strategy October 12, 2020 Like packaging designed to create a protective environment around a product, the mix of cells…
Cancer Drug News Potential drug treatment for particular type of lung-cancer October 7, 2020 The effectiveness of cancer treatment is often hampered by cancer cells being heterogeneous. This is…
Cancer Drug News Prostate cancer: immunotherapy offers hope October 2, 2020 An antibody for treating advanced prostate cancer improves progression-free survival in patients with metastasised, castration-resistant…
Cancer Drug News Gut microbiome may influence how cancer patients respond to oral therapies October 2, 2020 A new study from Lawson Health Research Institute and Western University illustrates how the gut…
Cancer Drug News Clinical trial of selpercatinib shows strong response for patients with non-small cell lung cancer September 30, 2020 An international team of researchers has found that selpercatinib, a drug that precisely targets cancers…
Cancer Drug News New drug targeting DNA repair shows promise in range of advanced cancers September 30, 2020 A new precision drug which stops cancer from repairing its DNA has shown promise in…
Cancer Drug News New vulnerability found in lung squamous cancer may facilitate drug targeting September 28, 2020 New cancer research by scientists at University of North Carolina Lineberger Comprehensive Cancer Center, USA,…
Cancer Drug News Scientists devise ‘Trojan horse’ approach to kill cancer cells without using drugs September 25, 2020 Cancer cells are killed in lab experiments and tumour growth reduced in mice, using a…
Cancer Drug News Why some cancers may respond poorly to key drugs discovered September 25, 2020 Patients with BRCA1/2 mutations are at higher risk for breast, ovarian and prostate cancers that…
Cancer Drug News ESMO 2020: Immunotherapy combination improves outcomes in advanced kidney cancer September 25, 2020 An immunotherapy agent combined with a tyrosine kinase inhibitor drug significantly improved progression-free survival and…